Smart scale trial aims to catch chemo problems early
NCT ID NCT06133426
Summary
This study is testing whether a smart scale that patients use at home can help doctors remotely monitor adults with lymphoma or myeloma who are getting chemotherapy. For about 7 weeks, 30 patients will weigh themselves daily. The scale sends data to the medical team, who can get alerts for concerning changes like sudden weight shifts, potentially allowing for earlier treatment. The study will also ask patients how easy the scale was to use and track if the alerts led to changes in care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA, NON-HODGKIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cochin Hospital
RECRUITINGParis, 75014, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.